BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 8956358)

  • 1. Phototesting in bath-PUVA: marked reduction of 8-methoxypsoralen (8-MOP) activity within one hour after an 8-MOP bath.
    Schempp CM; Schöpf E; Simon JC
    Photodermatol Photoimmunol Photomed; 1996 Jun; 12(3):100-2. PubMed ID: 8956358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation between 8-methoxypsoralen bath-water concentration and photosensitivity in bath-PUVA treatment.
    Tanew A; Kipfelsperger T; Seeber A; Radakovic-Fijan S; Hönigsmann H
    J Am Acad Dermatol; 2001 Apr; 44(4):638-42. PubMed ID: 11260539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetics and dose-response of photosensitivity in cream psoralen plus ultraviolet A photochemotherapy: comparative in vivo studies after topical application of three standard preparations.
    Grundmann-Kollmann M; Tegeder I; Ochsendorf FR; Zollner TM; Ludwig R; Kaufmann R; Podda M
    Br J Dermatol; 2001 May; 144(5):991-5. PubMed ID: 11359386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bath-5-methoxypsoralen-UVA therapy for psoriasis.
    Calzavara-Pinton PG; Zane C; Carlino A; De Panfilis G
    J Am Acad Dermatol; 1997 Jun; 36(6 Pt 1):945-9. PubMed ID: 9204060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time course of 8-methoxypsoralen-induced skin photosensitization in PUVA-bath photochemotherapy.
    Reuther T; Gruss C; Behrens S; von Kobyletzki G; Neumann N; Lehmann P; Altmeyer P; Kerscher M
    Photodermatol Photoimmunol Photomed; 1997; 13(5-6):193-6. PubMed ID: 9542757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinetics of photosensitivity in bath-PUVA photochemotherapy.
    Gruss C; Behrens S; Reuther T; Husebo L; Neumann N; Altmeyer P; Lehmann P; Kerscher M
    J Am Acad Dermatol; 1998 Sep; 39(3):443-6. PubMed ID: 9738780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phototoxicity of new psoralen-containing gels and creams versus bath PUVA.
    Nimkulrat P; Leenutaphong V; Sudtim S
    J Med Assoc Thai; 2005 Oct; 88(10):1406-11. PubMed ID: 16519387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer incidence among Finnish psoriasis patients treated with 8-methoxypsoralen bath PUVA.
    Hannuksela-Svahn A; Pukkala E; Koulu L; Jansén CT; Karvonen J
    J Am Acad Dermatol; 1999 May; 40(5 Pt 1):694-6. PubMed ID: 10321595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spatial distribution of 8-methoxypsoralen penetration into human skin after systemic or topical administration.
    Grundmann-Kollmann M; Podda M; Bräutigam L; Hardt-Weinelt K; Ludwig RJ; Geisslinger G; Kaufmann R; Tegeder I
    Br J Clin Pharmacol; 2002 Nov; 54(5):535-9. PubMed ID: 12445034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High plasma levels of 8-methoxypsoralen following bath water delivery in dermatological patients.
    Kappes UP; Barta U; Merkel U; Balogh A; Elsner P
    Skin Pharmacol Appl Skin Physiol; 2003; 16(5):305-12. PubMed ID: 12907835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carcinogenic risk of bath PUVA in comparison to oral PUVA therapy.
    Shephard SE; Panizzon RG
    Dermatology; 1999; 199(2):106-12. PubMed ID: 10559574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can the immersion time of PUVA bath therapy be shortened?
    Schiener R; Behrens-Williams SC; Pillekamp H; Kaskel P; Peter RU; Kerscher M
    Acta Derm Venereol; 2002; 82(1):18-20. PubMed ID: 12013191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of psoriasis with polyethylene sheet bath PUVA.
    Streit V; Wiedow O; Christophers E
    J Am Acad Dermatol; 1996 Aug; 35(2 Pt 1):208-10. PubMed ID: 8708022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of 8-MOP aqueous bath and 8-MOP ethanolic lotion (Meladinine) in local PUVA therapy.
    Shephard SE; Schregenberger N; Dummer R; Panizzon RG
    Dermatology; 1998; 197(1):25-30. PubMed ID: 9693181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation between bathing time and photosensitivity in 8-methoxypsoralen (8-MOP) bath PUVA.
    Dolezal E; Seeber A; Hönigsmann H; Tanew A
    Photodermatol Photoimmunol Photomed; 2000 Aug; 16(4):183-5. PubMed ID: 11019944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cream PUVA photochemotherapy].
    Stege H; Berneburg M; Ruzicka T; Krutmann J
    Hautarzt; 1997 Feb; 48(2):89-93. PubMed ID: 9173066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An intraindividual comparative study of psoralen-UVA erythema induced by bath 8-methoxypsoralen and 4, 5', 8-trimethylpsoralen.
    Man I; McKinlay J; Dawe RS; Ferguson J; Ibbotson SH
    J Am Acad Dermatol; 2003 Jul; 49(1):59-64. PubMed ID: 12833009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bath-water compared with oral delivery of 8-methoxypsoralen PUVA therapy for chronic plaque psoriasis.
    Collins P; Rogers S
    Br J Dermatol; 1992 Oct; 127(4):392-5. PubMed ID: 1419760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bath PUVA--an investigation of the distribution of trioxsalen (TMP) and 8-methoxypsoralen (8-MOP) in bathwater.
    Wainwright NJ; MacLeod TM; Ferguson J
    Photodermatol Photoimmunol Photomed; 1997; 13(1-2):17-20. PubMed ID: 9361123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of PUVA bath phototoxicity.
    Neumann NJ; Kerscher M; Ruzicka T; Lehmann P
    Acta Derm Venereol; 1997 Sep; 77(5):385-7. PubMed ID: 9298134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.